THE USE OF A NEW APPROACH TO PREVENTION AND THERAPY OF ACUTE ARTERIAL HYPERTENSION WITH COMPLEX OF WELL-KNOWN DRUGS WITH VEGETABLE GLYCOSIDES (EXPERIMENTAL STUDY)

Aim. To evaluate antihypertensive efficacy of nifedipine (N) and nifedipine complex (NC) in acute test in rats with adrenaline model of arterial hypertension. Material and methods. N is a conventional short acting formulation while NC is a new formulation of nifedipine in complex with glycyrrhizic acid. NC has an active substance 10 times less than N does in the same dose. Adrenaline which results in two times increase in blood pressure (BP) during 4 min was administered as a single i.v. dose (0,03 mg/kg) to normotensive unconscious male rats (body weight 190-220 g). NC and N were administered in the same dose (3,5 mg/kg) before and after adrenaline administration. Systolic BP recovering time was assessed. BP level was measured with direct method in carotid artery. Results. NC and N decreased in systolic BP in normotensive rats by 26 and 30% respectively. NC and N administered before adrenaline administration resulted in systolic BP recovering time reduction to 94,4 and 79,7 s respectively, which are less than this in control (204,8 s, р<0,001). Difference in time between NC and N is not significant (p<0,1). NC and N administered after adrenaline administration resulted in systolic BP recovering time reduction to 104,7 and 139 s respectively, which are also less than this in control (204,8 s, р<0,001). Difference in time between NC and N in this model is also not significant (p<0,1).  Conclusion. NC with contents of active substance 10 times less than in N showed antihypertensive efficacy similar with this in N. NC can be used for prevention and therapy of acute arterial hypertension.

1. Мартынов А.И., Гиляревский С.Р., Остроумова О.Д., Нестерова М.В., Мамаев В.И. // Тер. архив: Обзоры. - 2001. - №9.- С. 82

2. Толстиков Г.А., Балтина Л.А., Шульц Э.Э. и др. // Химия в интересах устойчивого развития. 1997. -Т. 5. № 1.- С. 57-73.

3. Толстиков Г.А., Муринов Ю.И., Балтина Л.А. и др. // Хим-фарм. журн. 1990. -№ 8.- С. 26-29.

4. Толстиков Г.А., Муринов Ю.И., Балтина Л.А и др. // Хим-фарм. журн. 1991.- № 2.- С. 29-31.

5. Бондарев А.И., Башкатов С.А., Давыдова В.А и др. // Фармакол. и токсикол. 1991.- №5.- С. 47-50.

6. Толстиков Г.А, Муринов Ю.И., Балтина Л.А. и др. // Хим-фарм. журн. 1991.- №3. -С. 42-45.

7. Регистр лекарственных средств - энциклопедия лекарств./ Гл. редактор Ю.Ф. Крылов. М.: «РЛС-2001», 2001.- С. 53.

8. Патент РФ № 2180583 // Бюллетень изобретения и полезные модели. 2002.- №8.- С.148.

9. Марцевич С.Ю. // Кардиология. 1999. -№9.- С. 91-96.

10. Современная концепция применения антагонистов кальция в кардиологии. Решение Ученого совета НИИ кардиологии им. А.Л.Мясникова КНЦ РАМН.// Кардиология. 1996.-№ 4. – С. 78 11. Furberg C.D., Psaty B.M., Meyer J.V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. //Ciculation 1995. – № 92:- С. 1326-1331

11. Трахтенберг И.М. и. др. Проблема нормы в токсикологии.// М. «Медицина». 1991. - С. 76-77

12. Духовная А.И., Курдянский Б.А., Кушнир Ю.К.//Гиг. и сан. – 1976.- №1.- С. 75-78.

13. N. E. Polyakov, M.B. Taraban, T. V. Leshina, Probing of the Structure and Properties of the Binding Site of Calcium Receptors by PhotoCIDNP Spectroscopy. Nifedipine – Receptor Interaction.// Photochem. Photobiol. 2004, submitted